Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-18-014750

Options or other derivatives

  • Chief Financial Officer acquired 35,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
NIFFENEGGER KATHI Chief Financial Officer 2018-03-12 Grant or award · Share Option (Right to Buy) +35,000 35,000 D
Loading xslF345X03/tv488519_4.xml…